MAPT and Alzheimer disease: Rapamycin, an inhibitor of the mTOR pathway, decreased Aβ deposition and prevented AD development by enhancing autophagy in an animal model of AD [71, 72], and the multifunctional protein p62 has been linked to neuropathological inclusions in various NDs and with the degradations of Aβ and tau.